Trv Gp II, LLC

10% owner at RVMD; 10% owner at Jounce Therapeutics, Inc.

Sold, on record
$46.3M
Dollars the filings state
Form 4 sales
3
Latest May 26, 2021
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
2
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. May 26, 2021Unusual

    RVMD

    Sold 71.6% of their holdings

    $41.8M1.4M shares at $30.57

    Filed May 27, 2021Form 4

  2. May 25, 2021Plan not stated

    Jounce Therapeutics, Inc.

    Sold 8.5% of their holdings

    $4.4M552,520 shares at $8.00

    Filed May 27, 2021Form 4

  3. Nov 17, 2020Plan not stated

    Jounce Therapeutics, Inc.

    Sold 0.2% of their holdings

    $109k15,000 shares at $7.25

    Filed Nov 19, 2020Form 4

3 of 3

Every transaction

Every transaction on a Form 4 or Form 5 by Trv Gp II, LLC
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
May 26, 2021May 27, 2021RVMD10% ownerSold1.4M$30.57$41.8M543,113SEC
May 25, 2021May 27, 2021Jounce Therapeutics, Inc.10% ownerSold552,520$8.00$4.4M5.9MSEC
Nov 17, 2020Nov 19, 2020Jounce Therapeutics, Inc.10% ownerSold15,000$7.25$109k9.2MSEC
May 17, 2017May 19, 2017Global Blood Therapeutics, Inc.10% ownerOther1M3.5MSEC
Apr 18, 2017May 19, 2017Global Blood Therapeutics, Inc.10% ownerGift51,708163,996SEC
Mar 30, 2017Apr 3, 2017MyoKardia Inc10% ownerOther850,0007.7MSEC
Nov 18, 2015Nov 18, 2015BPMC10% ownerOther1.3M40,290SEC
Jun 19, 2015Jun 22, 2015Sage Therapeutics, Inc.10% ownerOther1.1M27,331SEC

Sales and notices (3)

Form 144 notices and Form 4 sales by Trv Gp II, LLC
Source
May 26, 2021May 27, 2021RVMD10% ownerForm 4 sale1.4M$41.8M71.6%UnusualSEC
May 25, 2021May 27, 2021Jounce Therapeutics, Inc.10% ownerForm 4 sale552,520$4.4M8.5%Plan not statedSEC
Nov 17, 2020Nov 19, 2020Jounce Therapeutics, Inc.10% ownerForm 4 sale15,000$109k0.2%Plan not statedSEC